Sitagliptin Improved Beta Cell Function and Prevented a Conversion Rate to Impaired Glucose Tolerance and Type 2 Diabetes in Metformin Intolerant Obese Women With Polycystic Ovary Syndrome

NCT03122041 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

PCOS

Interventions

DRUG: Sitagliptin
BEHAVIORAL: Lifestyle intervention

Sponsor

University Medical Centre Ljubljana